Horacio Capelli

A comparative long-term follow-up of the results of anterior and posterior approaches in bypassing the rudimentary right ventricle in patients with tricuspid atresia

We have studied 44 patients with classical tricuspid atresia who underwent radical surgery between 1971 and 1985. Bypassing of the incomplete and rudimentary right ventricle was performed, in anterior fashion, in 17 patients operated on from 1971 to 1980. Subsequently, from 1980 to 1985, we used a technique of posterior retroaortic atriopulmonary anastomosis. This was undertaken in 27 patients. We have now compared the results in the two groups. Hospital and late mortality was 23.5 and 17.6% in those undergoing an anterior anastomosis, while it was 7.4 and 3.7% in those having a retroaortic connexion. When we compared the results in survivors, according to a previously designed clinical assessment score, we found that 41.1% of those undergoing the anterior approach were in excellent clinical status in comparison to 85.1% of those having a posterior anastomosis. The actuarial survival curve at 6 years showed 88.8% survival (70% confidence limit 44-77) for the posterior approach and 64.7% for the anterior. On the basis of our findings we felt able to remove from consideration as risk factors three of the features initially identified by Choussat and his colleagues. We conclude that better immediate and late results are obtained with the posterior retroaortic approach. We also found that those patients with excellent long-term outcome had postoperative right atrial pressures less than 14 mm Hg. Late arrhythmias were associated with increased right atrial pressures and were a relevant risk factor in both groups.

Development of pediatric and congenital heart surgery in latin america: accomplishments and remaining challenges.

In the last 70 years, congenital heart surgery has dramatically evolved, and Latin America has completed this journey with unique regional features. Since the first ligation of a patent arterial duct by Enrique Finochietto in 1941 in Buenos Aires, the development of congenital heart surgery was deeply influenced by funding restrictions and scarcity of technology. However, the determined work of cardiovascular surgery pioneers as Hugo Filipozzi, Euriclides Zerbini, and Adib Jatene in Brazil; Helmut Jaeger in Chile; Hugo Baz and Clemente Robles in Mexico; Alberto Bejarano in Colombia; and Mario Brea and Fernando Tricerri in Argentina made cardiac surgery with cardiopulmonary bypass available by the late 1950s. In the following five decades new generations of cardiovascular surgeons received the legacy of these outstanding leaders and made several important contributions to the field in tetralogy of Fallot, transposition of the great arteries, tricuspid atresia, single ventricle, truncus arteriosus, heart transplantation, and many others. Many centers in Latin America routinely perform congenital heart disease surgery with excellent results, covering the entire spectrum from the newborn to the adult congenital heart patient. The most important challenge that remains is to provide access to care to all children with congenital heart disease in Latin America, since currently only 42% of them receive surgical treatment.

Giant Neonatal Cardiac Tumor: Unusual Presentation and Natural History

16-day-old male newborn was admitted to our pediatric cardiac unit with symptoms of Acongestive heart failure. His mother had tuberous sclerosis (1). The echocardiographic study depicted a huge cardiac tumor emerging from the free wall of the left ventricle, encompassing the right ventricular free wall as well, that resembled a rhabdomyoma. There was no obstruction to the ventricular outflow tracts (A, Online Videos 1 and 2). The multislice computed tomography illustrates the enormous mass displacing the coronary arteries (B to G, Online Video 3). The surgical team determined that the tumor could not be excised. After 18 months of follow-up, he is doing well and the tumor is progressively shrinking (H to K, Online Videos 4 and 5). VI 1⁄4 left ventricle.